A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells
Open Access
- 15 May 2003
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 22 (19), 2950-2959
- https://doi.org/10.1038/sj.onc.1206423
Abstract
Interleukin-6 (IL-6) is a major survival factor for malignant plasma cells involved in multiple myeloma. Using an RNase protection assay, we looked for gene expression of 10 anti- and proapoptotic Bcl-2-family proteins in 12 IL-6-dependent human myeloma cell lines (HMCL). A high Mcl-1 gene expression was found in all HMCLs and the other genes were variably expressed. Out of the 10 Bcl-2-family members, only the Mcl-1 gene was regulated by IL-6. Upon starvation of IL-6, Mcl-1 gene expression decreased in association with myeloma cell apoptosis and was upregulated after adding IL-6 again in association with myeloma cell survival. A constitutive Mcl-1 expression was induced with an Mcl-1–GFP retrovirus in two IL-6-dependent HMCLs. The Mcl-1 HMCLs have a marked reduced apoptosis upon IL-6 starvation compared to HMCLs transduced with control GFP retrovirus and may grow without adding IL-6. These data emphasize the major role of Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells.Keywords
This publication has 49 references indexed in Scilit:
- Increased MCL–1 Expression Is Associated with Poor Prognosis in Ovarian CarcinomasJapanese Journal of Cancer Research, 2002
- Apaf-1/Cytochrome c-independent and Smac-dependent Induction of Apoptosis in Multiple Myeloma (MM) CellsJournal of Biological Chemistry, 2001
- Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1Cell Death & Differentiation, 2000
- IL-6 up-regulates Mcl-1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathwayEuropean Journal of Immunology, 1999
- Mcl‐1 and Bcl‐xL are co‐regulated by IL‐6 in human myeloma cellsBritish Journal of Haematology, 1999
- The effects on growth and survival of IL‐6 can be dissociated in the U‐266‐1970/U‐266‐1984 and HL407E/HL407L human multiple myeloma cell linesBritish Journal of Haematology, 1997
- SPECIFIC INHIBITION OF IL-6 SIGNALLING WITH MONOCLONAL ANTIBODIES AGAINST THE gp130 RECEPTORCytokine, 1997
- Human and Mouse Chromosomal Mapping of the Myeloid Cell Leukemia-1 Gene: MCL1 Maps to Human Chromosome 1q21, a Region That Is Frequently Altered in Preneoplastic and Neoplastic DiseaseGenomics, 1994
- In vivo interleukin 6 gene expression in the tumoral environment in multiple myelomaEuropean Journal of Immunology, 1991
- Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.The Journal of Experimental Medicine, 1989